ClinicalTrials.gg
Sign In

Papillomavirus Infections clinical trials

The registry lists 577 studies for Papillomavirus Infections across more than 10 countries. 131 are recruiting or about to start. 384 of them are mainly about Papillomavirus Infections (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-13. Counting its 3 narrower conditions too, such as Warts: 846 studies, 175 open.

ClinicalTrials.gov finds 969 studies for Papillomavirus Infections. How that becomes 575 here

This page counts the studies the registry files under Papillomavirus Infections, and those it files under no condition that list Papillomavirus Infectionsthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 969Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −189Filed under a narrower condition, counted on its own pageWarts 112 · Condylomata Acuminata 76
  3. −6List Papillomavirus Infections as a condition, but the registry did not file them under itMost often written as “Anal Canal HPV Infection Diagnosis” (1), “Cervical Persistent High Risk HPV Infection” (1), and “AIDS-Related Human Papillomavirus Infection” (1). The registry filed them under other conditions only, most often Uterine Cervical Dysplasia (2) and HIV Infections (2).
  4. −199Match it another way51 name it in the title, 2 in a keyword, and 146 by a synonym or other text the search reads.
  5. 575The count on this page9 of them list Papillomavirus Infections in their own words; the registry filed them under no condition.

Get an email when these change. Save the Papillomavirus Infections studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
307
Recruiting
85
Active, not recruiting
57
Status unknown
49
Not yet recruiting
41
Terminated
18

Phase

Phase 3
101
Phase 2
94
Phase 1
38
Phase 4
35
Early Phase 1
3

Where

United States
166
China
65
France
28
Canada
25
Spain
21
Italy
21

Who runs them

GlaxoSmithKline (72) · Merck Sharp & Dohme LLC (38) · National Cancer Institute (NCI) (20) · University of Washington (8) · AIDS Malignancy Consortium (8) · Fujian Maternity and Child Health Hospital (7) · Shanghai Bovax Biotechnology Co., Ltd. (7) · Shanghai Zerun Biotechnology Co.,Ltd (6)

What is being tested here

Drugs under test in Papillomavirus Infections studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Human Papillomavirus Recombinant Vaccine nonavalent101731
Zopapogene imadenovec314
Artesunate203
Epigallocatechin gallate203
Carboplatin104
Cisplatin113
Lactobacillus crispatus M247 Supplement102
Modified Influenza Virus Expressing HPV16 E6/E7 FluBHPVE6E7102
Glycyrrhizic Acid102
Folic Acid102

Drug classes tested here Immune checkpoint inhibitors 1 open · Antimitotic agents 3

Coming up

22phase 3 studies under way
62studies finish main data collection within a year7 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 85 Papillomavirus Infections studies recruiting now, 38 (45%) set no upper age limit and 42 (49%) stop at 75 or younger. 19 (22%) take children under 18. 54 (64%) are for women only and 3 (4%) for men only; 36 (42%) take healthy volunteers.

Recruiting studies that take each age, of 85
AgeWomenMen
1016 (19%)6 (7%)
1844 (52%)24 (28%)
3073 (86%)22 (26%)
4075 (88%)24 (28%)
5064 (75%)22 (26%)
6557 (67%)22 (26%)
7543 (51%)20 (24%)
8541 (48%)19 (22%)

Across all 576 studies, recruiting or not: 65% stop at 75 or younger and 61% at 65; 30% take children; 66% are for women only and 5% for men only; 59% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Papillomavirus Infections studies take

Of 60 phase 3 interventional studies under Papillomavirus Infections, half reached primary completion within 29 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 117 mo13–25 · 15 studies——
Phase 233 mo13–77 · 41 studies——
Phase 329 mo16–67 · 60 studies24 mo13–64 · 54 studies—
Phase 462 mo20–92 · 28 studies——
Interventional, no phase26 mo12–51 · 115 studies—26 mo12–48 · 106 studies
Observational46 mo24–90 · 66 studies—49 mo24–92 · 53 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Started recruiting4

Results posted1

Newly registered7

Show 2 more

Studies

Recruiting first, then most recently updated. Showing 50 of 577. Browse all 577 → or search them.